Cronos Capital Surpluse vs Other Liab Analysis

CRON Stock

USD 3.02 0.12 4.14%

Cronos financial indicator trend analysis is way more than just evaluating Cronos Group prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cronos Group is a good investment. Please check the relationship between Cronos Capital Surpluse and its Other Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cronos Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.

Capital Surpluse vs Other Liab

Capital Surpluse vs Other Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cronos Group Capital Surpluse account and Other Liab. At this time, the significance of the direction appears to have strong relationship.

The correlation between Cronos' Capital Surpluse and Other Liab is 0.78. Overlapping area represents the amount of variation of Capital Surpluse that can explain the historical movement of Other Liab in the same time period over historical financial statements of Cronos Group, assuming nothing else is changed. The correlation between historical values of Cronos' Capital Surpluse and Other Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Surpluse of Cronos Group are associated (or correlated) with its Other Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Liab has no effect on the direction of Capital Surpluse i.e., Cronos' Capital Surpluse and Other Liab go up and down completely randomly.

Correlation Coefficient

0.78

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Capital Surpluse

Other Liab

Most indicators from Cronos' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cronos Group current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cronos Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.

As of the 17th of May 2024, Tax Provision is likely to grow to about 30.6 M, while Discontinued Operations is likely to drop (472.5 K).

	2021	2022	2023	2024 (projected)
Reconciled Depreciation	15.4M	13.1M	9.6M	8.1M
Interest Income	9.1M	22.5M	46.5M	44.2M

Reconciled Depreciation Interest Income

Cronos fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Long Term Debt Total	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Non Currrent Assets Other	Other Assets	Good Will	Common Stock Total Equity	Capital Surpluse
Total Assets		0.82	0.87	1.0	-0.99	0.99	0.9	1.0	0.97	1.0	0.77	0.9	0.87	0.85	0.76	0.88	1.0	0.5	0.81	0.98	0.84	0.64	0.85	0.75	0.87	0.84
Other Current Liab	0.82		0.99	0.77	-0.77	0.87	0.87	0.79	0.84	0.81	0.32	0.56	0.68	0.63	0.36	0.98	0.8	0.36	0.55	0.7	0.77	0.69	0.65	0.96	0.51	0.44
Total Current Liabilities	0.87	0.99		0.83	-0.83	0.91	0.92	0.84	0.9	0.86	0.42	0.63	0.76	0.72	0.45	1.0	0.85	0.45	0.64	0.76	0.84	0.67	0.7	0.95	0.61	0.55
Total Stockholder Equity	1.0	0.77	0.83		-0.99	0.98	0.88	1.0	0.96	1.0	0.8	0.92	0.86	0.85	0.79	0.84	1.0	0.5	0.81	0.99	0.82	0.62	0.85	0.71	0.89	0.86
Net Debt	-0.99	-0.77	-0.83	-0.99		-0.97	-0.85	-0.99	-0.95	-0.99	-0.83	-0.89	-0.85	-0.82	-0.83	-0.84	-0.99	-0.44	-0.79	-0.98	-0.8	-0.59	-0.82	-0.69	-0.92	-0.88
Retained Earnings	0.99	0.87	0.91	0.98	-0.97		0.92	0.98	0.98	0.98	0.68	0.82	0.88	0.82	0.68	0.92	0.98	0.47	0.76	0.94	0.84	0.66	0.87	0.83	0.8	0.77
Accounts Payable	0.9	0.87	0.92	0.88	-0.85	0.92		0.86	0.96	0.87	0.54	0.74	0.87	0.87	0.57	0.93	0.87	0.61	0.77	0.82	0.95	0.74	0.79	0.9	0.69	0.67
Cash	1.0	0.79	0.84	1.0	-0.99	0.98	0.86		0.96	1.0	0.79	0.9	0.85	0.83	0.78	0.85	1.0	0.47	0.79	0.98	0.8	0.62	0.86	0.72	0.88	0.85
Non Current Assets Total	0.97	0.84	0.9	0.96	-0.95	0.98	0.96	0.96		0.96	0.68	0.85	0.92	0.91	0.68	0.91	0.96	0.63	0.84	0.92	0.93	0.69	0.86	0.82	0.81	0.78
Cash And Short Term Investments	1.0	0.81	0.86	1.0	-0.99	0.98	0.87	1.0	0.96		0.77	0.89	0.84	0.82	0.77	0.86	1.0	0.45	0.78	0.98	0.8	0.62	0.83	0.73	0.88	0.84
Net Receivables	0.77	0.32	0.42	0.8	-0.83	0.68	0.54	0.79	0.68	0.77		0.89	0.62	0.69	0.99	0.43	0.78	0.33	0.71	0.85	0.55	0.34	0.57	0.19	0.97	0.98
Common Stock Shares Outstanding	0.9	0.56	0.63	0.92	-0.89	0.82	0.74	0.9	0.85	0.89	0.89		0.81	0.88	0.87	0.65	0.9	0.58	0.88	0.94	0.76	0.58	0.72	0.45	0.92	0.9
Non Current Liabilities Total	0.87	0.68	0.76	0.86	-0.85	0.88	0.87	0.85	0.92	0.84	0.62	0.81		0.89	0.59	0.78	0.84	0.68	0.85	0.82	0.87	0.69	0.84	0.69	0.72	0.69
Other Current Assets	0.85	0.63	0.72	0.85	-0.82	0.82	0.87	0.83	0.91	0.82	0.69	0.88	0.89		0.67	0.74	0.83	0.85	0.93	0.83	0.95	0.62	0.77	0.61	0.78	0.78
Other Stockholder Equity	0.76	0.36	0.45	0.79	-0.83	0.68	0.57	0.78	0.68	0.77	0.99	0.87	0.59	0.67		0.46	0.78	0.27	0.71	0.84	0.56	0.34	0.52	0.24	0.97	0.98
Total Liab	0.88	0.98	1.0	0.84	-0.84	0.92	0.93	0.85	0.91	0.86	0.43	0.65	0.78	0.74	0.46		0.86	0.46	0.65	0.77	0.85	0.68	0.71	0.95	0.62	0.56
Total Current Assets	1.0	0.8	0.85	1.0	-0.99	0.98	0.87	1.0	0.96	1.0	0.78	0.9	0.84	0.83	0.78	0.86		0.46	0.79	0.99	0.8	0.62	0.84	0.72	0.88	0.85
Short Long Term Debt Total	0.5	0.36	0.45	0.5	-0.44	0.47	0.61	0.47	0.63	0.45	0.33	0.58	0.68	0.85	0.27	0.46	0.46		0.76	0.47	0.8	0.37	0.52	0.39	0.41	0.43
Other Liab	0.81	0.55	0.64	0.81	-0.79	0.76	0.77	0.79	0.84	0.78	0.71	0.88	0.85	0.93	0.71	0.65	0.79	0.76		0.81	0.85	0.52	0.67	0.51	0.79	0.78
Net Tangible Assets	0.98	0.7	0.76	0.99	-0.98	0.94	0.82	0.98	0.92	0.98	0.85	0.94	0.82	0.83	0.84	0.77	0.99	0.47	0.81		0.77	0.56	0.81	0.62	0.92	0.9
Property Plant And Equipment Net	0.84	0.77	0.84	0.82	-0.8	0.84	0.95	0.8	0.93	0.8	0.55	0.76	0.87	0.95	0.56	0.85	0.8	0.8	0.85	0.77		0.66	0.73	0.78	0.7	0.69
Non Currrent Assets Other	0.64	0.69	0.67	0.62	-0.59	0.66	0.74	0.62	0.69	0.62	0.34	0.58	0.69	0.62	0.34	0.68	0.62	0.37	0.52	0.56	0.66		0.72	0.69	0.4	0.37
Other Assets	0.85	0.65	0.7	0.85	-0.82	0.87	0.79	0.86	0.86	0.83	0.57	0.72	0.84	0.77	0.52	0.71	0.84	0.52	0.67	0.81	0.73	0.72		0.67	0.62	0.62
Good Will	0.75	0.96	0.95	0.71	-0.69	0.83	0.9	0.72	0.82	0.73	0.19	0.45	0.69	0.61	0.24	0.95	0.72	0.39	0.51	0.62	0.78	0.69	0.67		0.4	0.35
Common Stock Total Equity	0.87	0.51	0.61	0.89	-0.92	0.8	0.69	0.88	0.81	0.88	0.97	0.92	0.72	0.78	0.97	0.62	0.88	0.41	0.79	0.92	0.7	0.4	0.62	0.4		0.99
Capital Surpluse	0.84	0.44	0.55	0.86	-0.88	0.77	0.67	0.85	0.78	0.84	0.98	0.9	0.69	0.78	0.98	0.56	0.85	0.43	0.78	0.9	0.69	0.37	0.62	0.35	0.99

Click cells to compare fundamentals

Cronos Account Relationship Matchups

Cronos fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	2.1B	1.9B	1.4B	1.2B	1.1B	808.6M
Other Current Liab	297.2M	163.4M	14.4M	55.6M	28.1M	26.7M
Total Current Liabilities	332.9M	206.8M	54.4M	68.1M	41.2M	75.2M
Total Stockholder Equity	1.7B	1.7B	1.3B	1.1B	1.1B	730.3M
Net Debt	(1.2B)	(1.1B)	(877.2M)	(760.8M)	(663.3M)	(696.5M)
Retained Earnings	1.1B	1.1B	659.4M	490.7M	414.6M	373.4M
Accounts Payable	35.3M	42.1M	11.2M	11.2M	12.1M	13.2M
Cash	1.2B	1.1B	887.0M	764.6M	665.9M	463.1M
Non Current Assets Total	520.4M	553.5M	318.0M	252.9M	205.7M	209.8M
Cash And Short Term Investments	1.5B	1.3B	1.0B	877.7M	857.1M	557.1M
Net Receivables	16.5M	26.0M	33.3M	37.8M	35.7M	37.5M
Common Stock Shares Outstanding	342.8M	351.6M	370.4M	377.0M	381.0M	233.9M
Liabilities And Stockholders Equity	2.1B	1.9B	1.4B	1.2B	1.1B	808.6M
Non Current Liabilities Total	8.5M	10.7M	9.1M	3.9M	2.5M	4.5M
Other Current Assets	9.4M	12.3M	9.0M	7.1M	5.4M	5.8M
Other Stockholder Equity	23.2M	34.6M	32.5M	42.7M	48.2M	50.6M
Total Liab	341.4M	217.5M	63.5M	72.0M	43.7M	79.6M
Total Current Assets	1.6B	1.4B	1.1B	960.2M	928.5M	598.8M
Short Long Term Debt Total	7.1M	9.8M	9.8M	3.9M	2.5M	2.4M
Other Liab	1.8M	2.2M	2.0M	1.4M	1.6M	1.5M
Net Tangible Assets	1.5B	1.5B	1.3B	1.1B	1.3B	683.3M
Property Plant And Equipment Net	168.4M	197.4M	83.0M	62.8M	60.5M	83.2M
Non Currrent Assets Other	64.4M	87.7M	100K	72.5M	44.8K	42.5K
Other Assets	1.0	64.4M	116.7M	80.7M	72.5M	0.95
Good Will	214.8M	179.5M	1.1M	1.0M	1.1M	999.0K
Common Stock Total Equity	165.6M	561.2M	569.3M	595.5M	684.8M	719.1M
Short Term Investments	306.3M	211.8M	117.7M	113.1M	191.3M	103.4M
Capital Surpluse	11.3M	23.2M	34.6M	32.5M	37.3M	39.2M
Capital Lease Obligations	7.1M	9.8M	9.8M	3.9M	2.6M	3.6M
Inventory	38.0M	44.0M	32.8M	37.6M	30.3M	23.1M
Long Term Investments	557K	106.9M	135.2M	89.7M	54.7M	45.1M
Property Plant And Equipment Gross	166.5M	197.4M	83.0M	207.2M	200.6M	114.3M
Accumulated Other Comprehensive Income	27.8M	43.0M	49.9M	(797K)	20.6M	15.9M
Short Term Debt	427K	1.3M	2.7M	1.3M	988.9K	939.5K
Intangible Assets	72.3M	69.7M	18.1M	26.7M	21.1M	26.0M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Cronos Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cronos' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cronos Group Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cronos Group Stock:

How To Invest In Cronos

Details

Is Cronos Stock a good investment?

Details

What is Cronos' Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cronos Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.

You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Complementary Tools for Cronos Stock analysis

When running Cronos' price analysis, check to measure Cronos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cronos is operating at the current time. Most of Cronos' value examination focuses on studying past and present price action to predict the probability of Cronos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cronos' price. Additionally, you may evaluate how the addition of Cronos to your portfolios can decrease your overall portfolio volatility.

	Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
	Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios
	Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios
	Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
	Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities

Is Cronos' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cronos. If investors know Cronos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cronos listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.144

Earnings Share

(0.14)

Revenue Per Share

0.268

Quarterly Revenue Growth

0.255

Return On Assets

(0.04)

The market value of Cronos Group is measured differently than its book value, which is the value of Cronos that is recorded on the company's balance sheet. Investors also form their own opinion of Cronos' value that differs from its market value or its book value, called intrinsic value, which is Cronos' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cronos' market value can be influenced by many factors that don't directly affect Cronos' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Cronos' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cronos is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cronos' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Cronos Capital Surpluse vs Other Liab Analysis

Capital Surpluse vs Other Liab

Capital Surpluse vs Other Liab Correlation Analysis

Correlation Coefficient

Capital Surpluse

Other Liab

Cronos fundamental ratios Correlations

Cronos Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Cronos fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Cronos Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Cash	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Current Liabilities
Cash	+ 1.0	Total Stockholder Equity

Total Current Assets	- 0.99	Net Debt
Cash And Short Term Investments	- 0.99	Net Debt
Cash	- 0.99	Net Debt
Net Debt	- 0.99	Total Stockholder Equity
Net Debt	- 0.99	Total Assets
Net Tangible Assets	- 0.98	Net Debt